Your browser doesn't support javascript.
loading
A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.
Kulasingam, Shalini; Connelly, Luke; Conway, Elizabeth; Hocking, Jane S; Myers, Evan; Regan, David G; Roder, David; Ross, Jayne; Wain, Gerard.
Affiliation
  • Kulasingam S; Duke University, Center for Clinical Health Policy Research, Durham, NC 27710, USA. kulas002@mc.duke.edu
Sex Health ; 4(3): 165-75, 2007 Sep.
Article in En | MEDLINE | ID: mdl-17931529
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Mass Vaccination / Decision Support Techniques / Papillomavirus Infections / Human papillomavirus 16 / Papillomavirus Vaccines Type of study: Diagnostic_studies / Evaluation_studies / Health_economic_evaluation / Prognostic_studies / Screening_studies Aspects: Patient_preference Limits: Adolescent / Female / Humans Country/Region as subject: Oceania Language: En Journal: Sex Health Journal subject: DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2007 Document type: Article Affiliation country: United States Country of publication: Australia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Mass Vaccination / Decision Support Techniques / Papillomavirus Infections / Human papillomavirus 16 / Papillomavirus Vaccines Type of study: Diagnostic_studies / Evaluation_studies / Health_economic_evaluation / Prognostic_studies / Screening_studies Aspects: Patient_preference Limits: Adolescent / Female / Humans Country/Region as subject: Oceania Language: En Journal: Sex Health Journal subject: DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2007 Document type: Article Affiliation country: United States Country of publication: Australia